Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance

J Hepatol. 2015 Apr;62(4):982-3. doi: 10.1016/j.jhep.2014.12.028. Epub 2015 Jan 2.

Authors

Quentin M Anstee¹, Yang-Lin Liu², Christopher P Day², Helen L Reeves³

Affiliations

¹ Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle upon Tyne, UK. Electronic address: [email protected].
² Institute of Cellular Medicine, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
³ Northern Institute for Cancer Research, The Medical School, Newcastle University, Newcastle-upon-Tyne, UK.

PMID: 25559329
DOI: 10.1016/j.jhep.2014.12.028

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular / etiology*
Carcinoma, Hepatocellular / genetics*
Female
Humans
Lipase / genetics*
Liver Neoplasms / etiology*
Liver Neoplasms / genetics*
Male
Membrane Proteins / genetics*
Non-alcoholic Fatty Liver Disease / complications*
Non-alcoholic Fatty Liver Disease / genetics*
Polymorphism, Single Nucleotide*

Substances

Membrane Proteins
Lipase